Vous avez cherché: multipelt (Danois - Anglais)

multipelt abonnentnummer
multiple subscriber number

bredt multipelt bud
broad multiple bid

internationalt multipelt fjernsynskredsløb
international multiple destination television circuit

multipelt myelom program:
multiple myeloma program:

knoglemarvskræft (multipelt myelom);
a cancer of the bone marrow (multiple myeloma);

børn får ikke multipelt myelom.
children do not develop multiple myeloma.

triangulært multipelt forbundet blokdiagram
triangular multiply linked block design

a) tab af eller fejl i multipelt navigationsudstyr
a) loss or multiple navigation equipment failures

multipelt myelom er en sjælden progressiv blodsygdom.
multiple myeloma is a progressive rare haematologic disease.

anvendelse sammen med andre midler mod multipelt myelom
use in combination with other multiple myeloma treatment(s)

dosisjustering er ikke nødvendig ved behandling af multipelt myelom.
no dose adjustment is needed in the treatment of multiple myeloma.

studie 2 andre solide tumorer** eller multipelt myelom
study 2 other solid tumours** or multiple myeloma

neofordex gives sammen med andre lægemidler mod multipelt myelom.
neofordex will be given with other medicines for multiple myeloma.

dosisjustering for caelyx + bortezomib kombinationsbehandling ­ patienter med multipelt myelom
dosage adjustments for caelyx + bortezomib combination therapy -patients with multiple myeloma

dosisjustering for caelyx + bortezomib kombinationsbehandling – patienter med multipelt myelom
dosage adjustments for caelyx + bortezomib combination therapy - patients with multiple myeloma

- i kombination med bortezomib til behandlingen af progressivt multipelt myelom hos patienter,
- in combination with bortezomib for the treatment of progressive multiple myeloma in patients

dette kan medvirke til at reducere den hastighed, hvormed multipelt myelom udvikler sig.
this can help to slow down the progression of multiple myeloma.

der er ingen relevant anvendelse af neofordex hos den pædiatriske population til indikationen multipelt myelom.
there is no relevant use of neofordex in the paediatric population in the indication multiple myeloma.

bortezomib forårsager reduktion af tumorvækst in vivo i mange prækliniske tumormodeller, inklusive i multipelt myelom.
bortezomib causes reduction of tumour growth in vivo in many preclinical tumour models, including multiple myeloma.

virkningen af thalidomide celgene blev undersøgt i én hovedundersøgelse, hvori 447 patienter med multipelt myelom deltog.
the effectiveness of thalidomide celgene was studied in one main study involving 447 patients with multiple myeloma.